Abstract:We aimed to investigate the diagnostic and prognostic value of 68Ga-pentixafor PET/CT imaging in noncancer patients with suspected adrenal masses. Methods: Sixty-four patients who had benign adrenal masses on CT were retrospectively included in our study. All patients underwent 68Ga-pentixafor PET/CT, and 56 of these patients subsequently underwent adrenalectomy. The subtypes of 81 adrenal tumors, including 14 nonfunctioning adrenal nodules, 4 cortisol-producing adenomas, 41 aldosterone-producing adenomas, 5 cases of suspected unilateral adrenal hyperplasia, 15 cases of idiopathic aldosterone hyperplasia, and 2 pheochromocytomas, were determined by histology or follow-up evaluations. The diagnostic efficiency of functional lateralization was calculated by visual analysis. Semiquantitative parameters of these lesions, including SUVmax, the ratio of lesional SUVmax to normal liver SUVmean (LLR), and the ratio of lesional SUVmax to contralateral adrenal tissue SUVmean (LCR), were also calculated. Dynamic analysis was also performed on 15 patients. In addition, clinical outcomes were assessed and compared in patients who underwent adrenalectomy. Results: The sensitivity and specificity of 68Ga-pentixafor PET for functional lateralization in patients with adrenocortical lesions were 97.8% (45/46) and 87.5% (14/16), respectively. The 2 pheochromocytoma lesions had lower pentixafor uptake than the normal adrenal glands. Functioning (active) adrenocortical adenomas showed an elevated SUVmax of 16.3 ± 7.9, in comparison to 4.4 ± 1.7 in nonfunctioning (inactive) adenomas and 5.5 ± 2.7 in hyperplasia lesions (P < 0.0001). To identify active adrenocortical adenomas, a cutoff of 7.1 for SUVmax showed a sensitivity of 90.9% and a specificity of 85.3% (area under receiver-operating-characteristic curve, 0.96; P < 0.0001); a cutoff of 2.5 for LLR showed a sensitivity of 95.5% and a specificity of 88.2% (area under receiver-operating-characteristic curve, 0.97; P < 0.0001); and a cutoff of 2.4 for LCR showed a sensitivity of 88.6% and a specificity of 91.8% (area under receiver-operating-characteristic curve, 0.95; P < 0.0001). The graphical influx rate constant of active adrenocortical adenomas was significantly higher than that of inactive adenomas. Uptake values for 68Ga-pentixafor were significantly higher in patients with preferable outcomes (cured/improved) (SUVmax, 15.5 ± 8.0; LLR, 6.5 ± 4.3; LCR, 6.2 ± 5.0) than in patients with nonpreferable outcomes (no improvement) (SUVmax, 4.2 ± 0.5; LLR, 1.3 ± 0.2; LCR, 1.5 ± 0.6; all P < 0.0001). Conclusion:68Ga-pentixafor PET/CT imaging exhibits great potential for noninvasive functional lateralization and characterization in patients with adrenocortical masses.

The Diagnostic Value of 18F-FDG PET/CT in the Localization of Ectopic Adrenocorticotrophic Hormone-Secreting Tumors

The Role of Integrated 18 F-FDG PET/CT in Identification of Ectopic ACTH Secretion Tumors

Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome.

3 Cases of Ectopic ACTH Pituitary Adenoma and Literature Review

18F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor

Diagnostic performance of various imaging modalities in localizing Ectopic ACTH syndrome: A Systematic review

18F-FDG PET Imaging for Differentiating Malignant from Benign Lesions in Patients with Adrenal Masses

Case Report: An Unusual Case of Ectopic ACTH Syndrome Caused by Mediastinal Paraganglioma

Utility of 11C-Methionine and 18F-Fdg Pet/Ct in Patients with Functioning Pituitary Adenomas

Correlation between degree of malignancy of pheochromocytoma and standardized uptake value (SUV) measured by 18F-FDG PET/CT

Surgical Treatment of Ectopic Adrenocorticotropic Hormone Syndrome with Intra-Thoracic Tumor.

Ectopic Cushing Syndrome Localized by 68 Ga-DOTA-LM3 PET/CT

Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using 68Ga-Pentixafor.

Usefulness of 68Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome

Prospective Study of 17 Cases with Ectopic ACTH Syndrome

Correlation between the degree of malignancy of pheochromocytoma and the maximum standardized uptake value measured by 18F-FDG PET/CT

PET/CT in Patients With Functioning Pituitary Adenomas

The Diagnosis of 18 F-fluorodexoxyglucose and 11C-Acetate PET/CT Scanning in Primary Liver Tumors and Tumor-Like Diseases : a Preliminary Study

Cortisol-Producing Adrenal Adenomas with Intense Activity on 68Ga-Pentixafor PET/CT

Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.

Diagnostic value of CT for extra-adrenal pheochromocytoma